Palisade Bio, Inc. - Common Stock (PALI)

Get a pulse on the US markets on Thursday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity.

Unusual volume stocks in Monday's session

Which stocks have an unusual volume on Friday?

Palisade Bio progresses its Phase 1 study for PALI-2108, showing safety and targeted bioactivation, with topline data anticipated in early 2025.

Let's have a look at what is happening on the US markets on Friday. Below you can find the stocks with an unusual volume in today's session.

Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.

PALI stock results show that Palisade Bio missed analyst estimates for earnings per share the second quarter of 2024.

PALI stock results show that Palisade Bio beat analyst estimates for earnings per share the first quarter of 2024.